Protara Therapeutics to Present at Upcoming Virtual Investor Conferences
February 04 2021 - 8:00AM
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage
company developing transformative therapies for the treatment of
cancer and rare diseases with significant unmet needs, today
announced that management will present at two upcoming virtual
investor conferences:
- Guggenheim Healthcare Talks 2021
Oncology Days on Thursday, February 11, 2021 at 9:30am ET
- Cowen 41st Annual Health Care
Conference on Wednesday, March 3, 2021 at 1:20pm ET
A webcast of the fireside chat presentations can
be accessed by visiting the Events and Presentations section of the
Company’s website: https://ir.protaratx.com. The webcasts will
be archived on the Company’s website for 90 days following the
presentations.
About Protara Therapeutics, Inc.
Protara is committed to identifying and
advancing transformative therapies for people with cancer and rare
diseases with limited treatment options. Protara’s portfolio
includes its lead program, TARA-002, an investigational cell-based
therapy being developed for the treatment of non-muscle invasive
bladder cancer and lymphatic malformations, and IV Choline
Chloride, an investigational phospholipid substrate replacement
therapy for the treatment of intestinal failure-associated liver
disease. For more information, visit www.protaratx.com.
Company Contact:
Justine O'MalleyProtara
TherapeuticsJustine.OMalley@protaratx.com646-817-2836
Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
From Apr 2023 to Apr 2024